Herb in Thai notifiable formulas

Spikenard

โกฐชฎามังสี · Kot Chatamangsi

Nardostachys jatamansi (D. Don) DC.

Family
Caprifoliaceae
Part used
root and rhizome
Crude drug
Nardostachyos Radix et Rhizoma
Other names
Chinese Spikenard, Jatamansi
In the announcement
Used in 3 notifiable formulas
Spikenard, dried root and rhizome, with remnants of stem and leaves,
Photo: Plantagenet · Wikimedia Commons · CC BY-SA 4.0 · resized
Thai Herbal Pharmacopoeia (THP)

Constituents and quality criteria of Spikenard

Summarised from the Spikenard monograph of the Thai Herbal Pharmacopoeia, Department of Medical Sciences, the standard used to test the dried root and rhizome, with remnants of stem and leaves,.

The pharmacopoeia sets no minimum marker content for this herb. Use the raw material quality criteria below for acceptance testing.

Constituents

Spikenard contains volatile oil of which sesquiterpenoids (e.g., jatamansone or valeranone, nardosinone) are its major components. It also contains other sesquiterpenoids (e.g., nardin), alkaloids (e.g., actinidine), coumarins, etc.

Raw material quality criteria

Foreign matterNot more than 2.0% w/w
Total ashNot more than 11.0% w/w
Acid-insoluble ashNot more than 6.0% w/w
Water-soluble extractiveNot less than 5.0% w/w
Ethanol-soluble extractiveNot less than 2.0% w/w
Volatile oilNot less than 1.0% v/w

Storage: Spikenard shall be kept in well-closed containers, preferably of metal or glass, protected from light, and stored in a cool and dry place.

Source: Thai Herbal Pharmacopoeia, Department of Medical Sciences (online edition, accessed 21 October 2026)Read the full THP monograph
Development potential

Develop Spikenard into a product with the TIBD group

In notifiable formulas3 formulasused in multi-herb formulas
THP raw-material criteria6 testsfor acceptance testing before production
Marker with a minimum contentNot setquality is checked with the raw-material criteria

Three ways forward 1Notify a listed formula2Adapt it through detailed notification3Develop a Category B herbal medicine or Category C health productSee the development pathway